Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New indoles acting as DP receptor antagonists in the Ono pipeline

Nov. 6, 2001

Inhaled iseganan safe in cystic fibrosis patients

Nov. 5, 2001

Xolair BLA amendment will be submitted in the fourth quarter of 2002

Nov. 5, 2001

Abbott's new H3 receptor antagonists described in recent patent

Nov. 2, 2001

Nonemetogenic PDE4 inhibitors result from R&D at Inflazyme

Oct. 31, 2001

Potent and selective PDE4 inhibitors claimed by Sanofi-Synthelabo in patent literature

Oct. 30, 2001

PDE4-inhibitory heterocyclic carboxamides patented by Merck

Oct. 29, 2001

Demegen expands pipeline for treatment of cystic fibrosis through CFF grant

Oct. 25, 2001

Yamanouchi presents new inhibitors of CRACC and IL-2 production

Oct. 22, 2001

Potent elastase inhibitors with low toxicity reported by Cermol

Oct. 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...